STAAR Surgical Co. (STAA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

iRhythm Technologies, Inc.

AtriCure, Inc.

ICU Medical, Inc.

LivaNova Plc

Integer Holdings Corp.

Axonics, Inc.

CONMED Corp.

InMode Ltd.

Pacific Biosciences of California, Inc.

STAAR Surgical Co.

Integra LifeSciences Holdings Corp.

Why is STAAR Surgical Co. ?

Poor Management Efficiency with a low ROE of 5.89%

The company has been able to generate a Return on Equity (avg) of 5.89% signifying low profitability per unit of shareholders funds

Negative results in Jun 25

NET SALES(Q) At USD 44.32 MM has Fallen at -55.23%
PRE-TAX PROFIT(Q) At USD -20.67 MM has Fallen at -299.99%
NET PROFIT(Q) At USD -11.56 MM has Fallen at -256.72%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -8.20%, its profits have fallen by -564.6%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -8.20% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is STAAR Surgical Co. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

STAAR Surgical Co.

0.42%

-0.44

71.30%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.64%

EBIT Growth (5y)

-287.61%

EBIT to Interest (avg)

8.83

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.63

Sales to Capital Employed (avg)

0.80

Tax Ratio

15.90%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

22.61%

ROE (avg)

5.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.53

EV to EBIT

-9.83

EV to EBITDA

-11.15

EV to Capital Employed

5.09

EV to Sales

2.39

PEG Ratio

Dividend Yield

ROCE (Latest)

-51.79%

ROE (Latest)

-20.31%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-34What is not working for the Company

NET SALES(Q)

At USD 44.32 MM has Fallen at -55.23%

PRE-TAX PROFIT(Q)

At USD -20.67 MM has Fallen at -299.99%

NET PROFIT(Q)

At USD -11.56 MM has Fallen at -256.72%

OPERATING CASH FLOW(Y)

Lowest at USD -28.52 MM

ROCE(HY)

Lowest at -25.55%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.43 times

RAW MATERIAL COST(Y)

Grown by 10.12% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -44.38 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.38 times

Here's what is not working for STAAR Surgical Co.

Net Sales

At USD 44.32 MM has Fallen at -55.23%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -20.67 MM has Fallen at -299.99%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -11.56 MM has Fallen at -256.72%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Inventory Turnover Ratio

Lowest at 1.43 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow

Lowest at USD -28.52 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debt-Equity Ratio

Highest at -44.38 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 3.38 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 10.12% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales